Softgel Machine Market Size, Share, Growth, and Industry Analysis, By Type (Soft Capsule Encapsulation Machines, Soft Capsule Drying Systems, Other Auxiliary Devices), By Application (Pharmacy, Health Supplements, Others), Regional Insights and Forecast to 2035

Softgel Machine Market Overview

The global Softgel Machine Market size estimated at USD 393.8 million in 2026 and is projected to reach USD 1108.43 million by 2035, growing at a CAGR of 12.19% from 2026 to 2035.

The Softgel Machine Market is expanding due to rising production of pharmaceutical capsules, nutraceutical supplements, and cosmetic softgels across more than 85 countries. Soft capsule manufacturing facilities processed over 420 billion softgel capsules during 2025, increasing demand for high-speed encapsulation systems capable of producing 120,000 capsules per hour. Rotary die encapsulation equipment accounts for 46% of total machine installations worldwide, while automated production lines represent 61% of new manufacturing investments. More than 58% of equipment demand originates from pharmaceutical manufacturing applications. Growing adoption of vegetarian softgel technology, precision filling systems, and integrated drying units continues to strengthen equipment replacement cycles across major production facilities.

The United States remains one of the largest consumers of softgel manufacturing equipment, supported by more than 1,500 nutraceutical production facilities and over 900 pharmaceutical dosage manufacturing plants. Nearly 63% of dietary supplement capsules sold in the country are produced using softgel formats due to higher bioavailability and easier swallowing characteristics. Automated encapsulation systems account for 72% of new machinery purchases across U.S. manufacturing sites. More than 48 million adults in the country consume dietary supplements daily, creating consistent demand for softgel production capacity. Domestic manufacturers increasingly adopt digital monitoring systems, with 68% of newly installed machines incorporating touchscreen controls and real-time process validation technologies.

Download Free Sample to learn more about this report.

Key Findings

• Key Market Driver: Pharmaceutical applications contribute 58%, nutraceutical demand contributes 27%, automation adoption reaches 61%, high-speed encapsulation systems account for 46%, and precision dosing requirements influence 64% of purchasing decisions across global manufacturing facilities.
• Major Market Restraint: Equipment maintenance expenses affect 39% of manufacturers, skilled operator shortages impact 34%, production downtime concerns reach 28%, validation complexity influences 31%, and environmental sensitivity affects 40% of operational facilities.
• Emerging Trends: Vegetarian capsule technology represents 22% of installations, Industry 4.0 integration reaches 43%, automated monitoring systems account for 68%, energy-efficient machinery adoption stands at 37%, and digital controls influence 59% of upgrades.
• Regional Leadership: North America holds 35% market share, Europe accounts for 29%, Asia-Pacific reaches 28%, Middle East & Africa represent 8%, while pharmaceutical equipment investments exceed 62% within leading manufacturing regions.
• Competitive Landscape: Top five manufacturers control 54% of global installations, automated equipment contributes 61% of product portfolios, export-focused production reaches 48%, customized machinery accounts for 33%, and integrated systems represent 57% of sales.
• Market Segmentation: Soft capsule encapsulation machines hold 52% share, drying systems account for 29%, auxiliary devices represent 19%, pharmaceutical applications reach 58%, health supplements contribute 31%, and other applications account for 11%.
• Recent Development: Smart control integration increased 44%, plant-based softgel compatibility expanded 26%, production efficiency improved 18%, digital validation systems reached 52% adoption, and automated inspection technology accounted for 41% of launches.

Softgel Machine Market Latest Trends

The Softgel Machine Market is witnessing significant transformation through automation, digital process control, and plant-based capsule manufacturing technologies. More than 68% of newly installed encapsulation systems now include programmable logic controllers and touchscreen interfaces. Manufacturers are increasingly investing in machines capable of producing 80,000 to 120,000 capsules per hour to meet rising pharmaceutical and nutraceutical demand. Vegetarian softgel production equipment accounted for 22% of total installations during 2025, compared with 17% recorded three years earlier. Continuous drying systems improved production efficiency by 19%, while automated sorting technologies reduced rejection rates by 14%.

Another important trend involves integration of real-time monitoring systems. Approximately 59% of advanced softgel production lines now incorporate automated temperature regulation and fill-weight verification technologies. Energy-efficient motors reduced electricity consumption by 16% across newly commissioned facilities. Contract manufacturing organizations represent 36% of equipment purchases due to increasing outsourcing activities in pharmaceutical production. Asia-based manufacturers expanded exports by 24%, while customized encapsulation equipment orders increased by 28%. Demand for multi-format machines capable of producing oval, round, tube, and twist-off capsules grew by 32%, reflecting rising diversification in product portfolios among pharmaceutical and supplement manufacturers.

Softgel Machine Market Dynamics

DRIVER

" Rising demand for pharmaceuticals and nutraceutical supplements."

Global demand for pharmaceutical softgels and dietary supplements continues to drive equipment purchases across manufacturing facilities. Pharmaceutical applications account for 58% of total softgel machine utilization worldwide. More than 4 billion dietary supplement units are consumed annually across North America alone, increasing production requirements for encapsulation machinery. Automated softgel systems capable of producing 100,000 capsules per hour have experienced installation growth of 27% since 2022. Aging populations across developed countries contribute to increased consumption of omega-3, vitamin D, and prescription softgel formulations. Approximately 64% of manufacturers prioritize investments in advanced encapsulation systems to improve productivity, consistency, and compliance with pharmaceutical quality standards.

RESTRAINT

"Demand for refurbished equipment and high operational complexity."

Refurbished machinery remains a significant challenge for new equipment suppliers. Nearly 31% of medium-sized manufacturers purchase refurbished encapsulation systems due to lower capital expenditure requirements. Maintenance costs account for approximately 18% of annual operating expenses in softgel production facilities. Complex installation requirements increase commissioning periods by an average of 90 days for large-scale production lines. Around 34% of facilities report shortages of trained technicians capable of operating advanced encapsulation equipment. Validation procedures required by pharmaceutical regulations can extend equipment deployment timelines by 20%, while machine calibration and cleaning requirements contribute to production downtime levels approaching 12% annually.

OPPORTUNITY

" Growth in personalized medicines and plant-based softgel formulations."

Personalized healthcare and vegetarian softgel formulations are creating substantial opportunities for equipment manufacturers. Plant-based softgel demand increased by 26% during 2025, encouraging manufacturers to develop compatible encapsulation systems. More than 42% of nutraceutical companies have introduced customized supplement formulations targeting specific consumer groups. Flexible production machines capable of handling multiple capsule sizes experienced demand growth of 29%. Emerging markets across Asia and Latin America expanded pharmaceutical manufacturing capacity by 23%, generating new equipment procurement opportunities. Contract manufacturing organizations accounted for 36% of equipment investments, while digital production tracking technologies were adopted by 52% of newly established production facilities.

CHALLENGE

" Rising production costs and strict compliance requirements."

Manufacturers face increasing pressure from operational costs and regulatory compliance requirements. Raw material price fluctuations affect approximately 37% of production planning activities. Quality validation processes require detailed monitoring of temperature, humidity, and fill accuracy, increasing compliance workloads by 21%. More than 48% of manufacturers report challenges related to maintaining consistent capsule quality across high-volume production batches. Energy expenses account for nearly 14% of total operating costs in large encapsulation facilities. Equipment suppliers must continuously upgrade systems to satisfy evolving pharmaceutical standards, while cybersecurity concerns impact 19% of facilities implementing connected manufacturing technologies and cloud-based monitoring platforms.

Softgel Machine Market Segmentation 

The Softgel Machine Market is segmented by equipment type and application area. Soft capsule encapsulation machines account for 52% of market demand because they represent the core production technology used in pharmaceutical and nutraceutical manufacturing. Soft capsule drying systems contribute 29% due to their essential role in moisture control and capsule stabilization. Auxiliary devices represent 19% of installations, supporting sorting, inspection, and packaging functions. By application, pharmaceutical manufacturing leads with 58% share, while health supplements account for 31%. Other industrial applications represent 11%, including cosmetics, veterinary products, and specialty nutrition formulations. Automation levels exceed 61% across newly installed equipment segments.

Download Free Sample to learn more about this report.

BY TYPE

Soft Capsule Encapsulation Machines: Soft capsule encapsulation machines represent approximately 52% of total market demand and remain the primary equipment category within the industry. Modern rotary die systems produce up to 120,000 capsules per hour and achieve fill-weight accuracy above 98%. More than 61% of pharmaceutical facilities utilize fully automated encapsulation equipment to improve consistency and production efficiency. These machines support multiple capsule shapes, including oval, round, oblong, and tube formats. Demand increased by 24% across nutraceutical manufacturing facilities due to rising consumption of vitamin and omega-based products. Advanced systems equipped with programmable controls account for 68% of new installations worldwide, improving process monitoring and reducing material waste by 15%.

Soft Capsule Drying Systems: Soft capsule drying systems account for approximately 29% of market share and are critical for maintaining capsule stability and quality. Tumble drying systems reduce moisture content by nearly 35% during initial processing stages. Continuous drying tunnels improve throughput by 18% compared with conventional drying methods. More than 57% of large-scale production facilities have upgraded to automated drying solutions equipped with humidity monitoring sensors. Proper drying operations reduce capsule deformation rates below 2%, improving overall production quality. Pharmaceutical manufacturers represent 63% of drying system purchases due to stringent quality requirements. Energy-efficient drying technologies reduced electricity consumption by 16% across newly installed systems during recent equipment modernization projects.

Other Auxiliary Devices: Auxiliary devices contribute approximately 19% of market demand and include sorting equipment, inspection units, gelatin preparation systems, and packaging support machinery. Automated sorting systems process more than 250,000 capsules per hour while reducing manual labor requirements by 32%. Vision inspection technologies detect defects with accuracy levels exceeding 97%. Gelatin melting and preparation units account for 41% of auxiliary equipment installations due to their importance in maintaining capsule consistency. More than 54% of newly established production lines include integrated auxiliary systems to enhance operational efficiency. Demand for automated inspection and rejection technologies increased by 21%, driven by pharmaceutical compliance requirements and quality assurance initiatives.

BY APPLICATION

Pharmacy: Pharmacy applications account for approximately 58% of total market utilization, making them the largest application segment. Pharmaceutical manufacturers produce billions of prescription and over-the-counter softgel capsules annually for pain management, cardiovascular treatments, and vitamin therapies. More than 70% of softgel-based prescription formulations require precision encapsulation systems capable of maintaining fill-weight accuracy above 98%. Regulatory compliance requirements drive investments in automated monitoring technologies, which are installed in 64% of pharmaceutical production facilities. North America and Europe collectively account for 57% of pharmaceutical equipment demand. Increasing development of lipid-based drug delivery systems has expanded utilization of advanced softgel machinery across global pharmaceutical manufacturing networks.

Health Supplements: Health supplements represent approximately 31% of market demand and continue to experience strong equipment utilization rates. More than 48 million adults in the United States consume dietary supplements daily, supporting large-scale softgel production requirements. Omega-3, vitamin D, multivitamin, and herbal extract formulations account for over 62% of supplement-based softgel manufacturing. Automated encapsulation systems reduce production waste by 15% while improving throughput by 20%. Nutraceutical companies increasingly invest in vegetarian capsule technology, which represents 22% of supplement-related equipment purchases. Asia-Pacific contributes 34% of global supplement manufacturing activity, creating substantial demand for medium-capacity and high-capacity softgel production machinery.

Others: Other applications account for approximately 11% of market share and include cosmetics, veterinary healthcare products, and specialty nutrition formulations. Cosmetic softgels containing beauty supplements increased production volumes by 19% during 2025. Veterinary pharmaceutical manufacturers utilize softgel technologies for pet nutrition and animal healthcare products, accounting for 27% of this application category. Specialty nutrition products designed for sports performance represent 22% of non-pharmaceutical softgel production. Flexible encapsulation equipment capable of handling customized formulations increased demand by 18%. More than 41% of manufacturers serving these applications prefer modular machinery designs that allow rapid product changes and efficient small-batch production capabilities.

Softgel Machine Market Regional Outlook

Regional performance in the Softgel Machine Market reflects pharmaceutical production capacity, supplement consumption trends, and manufacturing investments. North America leads with 35% market share due to advanced pharmaceutical infrastructure. Europe follows with 29% supported by strict quality standards and equipment modernization. Asia-Pacific accounts for 28% owing to rapid pharmaceutical expansion and contract manufacturing growth. Middle East & Africa contribute 8% through increasing healthcare investments and local production initiatives. Automation adoption exceeds 60% in North America and Europe, while Asia-Pacific records the fastest equipment installation growth supported by expanding nutraceutical and pharmaceutical manufacturing activities.

Download Free Sample to learn more about this report.

NORTH AMERICA

North America accounts for approximately 35% of the global Softgel Machine Market. The region benefits from a large pharmaceutical manufacturing base, advanced healthcare infrastructure, and strong dietary supplement consumption. The United States represents nearly 81% of regional equipment demand, supported by more than 1,500 nutraceutical production facilities. Automated encapsulation systems account for 72% of new equipment purchases throughout the region. Pharmaceutical applications contribute approximately 61% of machine utilization, while health supplements account for 29%. Manufacturers continue to invest in advanced technologies that improve productivity and compliance. More than 67% of recently installed machines include digital monitoring systems and automated quality control functions. Contract manufacturing organizations represent 38% of equipment procurement activities due to increasing outsourcing of pharmaceutical production. High-speed encapsulation systems capable of producing 120,000 capsules per hour experienced installation growth of 22% during the past three years. Demand for vegetarian softgel equipment increased by 24%, reflecting changing consumer preferences.

EUROPE

Europe holds approximately 29% of the global Softgel Machine Market and remains a major center for pharmaceutical equipment manufacturing and innovation. Germany, Italy, France, and the United Kingdom collectively account for more than 68% of regional machine demand. Pharmaceutical applications contribute 60% of utilization rates across European facilities. More than 58% of production sites operate automated encapsulation lines equipped with real-time quality monitoring systems. Germany represents the largest equipment consumer in the region, supported by advanced pharmaceutical manufacturing and engineering capabilities. Italy maintains a strong presence through packaging and processing equipment expertise. Approximately 47% of European manufacturers have upgraded production lines within the last five years to improve efficiency and regulatory compliance. Continuous drying systems and automated sorting technologies experienced adoption increases of 19% and 23%, respectively.

ASIA-PACIFIC

Asia-Pacific accounts for approximately 28% of global market share and represents the fastest-expanding production hub for pharmaceutical and nutraceutical manufacturing. China, India, Japan, and South Korea collectively contribute more than 74% of regional equipment demand. Pharmaceutical manufacturing expansion and contract production services continue driving investments in encapsulation technologies. Automated machine installations increased by 26% across the region during recent years. China remains the largest regional market, supported by extensive pharmaceutical production capacity and growing supplement consumption. India records strong equipment demand due to expansion of pharmaceutical exports and contract manufacturing activities. More than 42% of newly established facilities in the region utilize fully automated production lines. Nutraceutical applications account for 34% of machine utilization rates, higher than most other regions.

MIDDLE EAST & AFRICA

Middle East & Africa account for approximately 8% of global market share. Although smaller than other regions, healthcare infrastructure development and pharmaceutical localization programs continue supporting equipment demand. Saudi Arabia, the United Arab Emirates, and South Africa represent more than 61% of regional machine purchases. Pharmaceutical applications contribute approximately 57% of equipment utilization across local manufacturing facilities. Government initiatives aimed at reducing dependence on imported medicines have encouraged investments in domestic pharmaceutical production. More than 21 new manufacturing facilities have been announced or expanded across key regional markets since 2023. Automated encapsulation equipment accounts for 44% of newly installed machinery, reflecting ongoing modernization efforts. Demand for dietary supplement manufacturing systems increased by 18% as consumer health awareness continues rising.

List of Top Softgel Machine Companies

• Changsung Softgel System
• Technophar
• SKY SOFTGEL & PACK
• Pharmagel
• GIC Engineering
• Sankyo
• Tooltronics
• Long March Tianmin
• Kamata
• Bochang

List of Top 2 Companies Market Share

Changsung Softgel System: Holds approximately 17% of global installations, supported by more than 50 years of manufacturing experience and extensive deployment across pharmaceutical, nutraceutical, and cosmetic production facilities.

Technophar: Accounts for approximately 14% of global market presence, supported by advanced encapsulation technologies, automated production systems, and strong penetration across North America and international pharmaceutical manufacturing facilities.

Investment Analysis and Opportunities

Investment activity within the Softgel Machine Market remains focused on automation, pharmaceutical expansion, and advanced manufacturing technologies. More than 61% of capital expenditure projects involve fully automated encapsulation systems equipped with digital controls and real-time monitoring capabilities. Pharmaceutical manufacturers account for approximately 58% of equipment investments, while nutraceutical companies contribute 31%. Asia-Pacific attracted nearly 38% of new production facility investments during 2025 due to lower manufacturing costs and expanding healthcare demand.

Opportunities are increasing in vegetarian softgel production technologies, where demand expanded by 26% during the past year. Automated inspection systems achieved investment growth of 21%, while continuous drying technologies recorded installation growth of 19%. Contract manufacturing organizations represent 36% of equipment procurement activities, creating strong opportunities for machinery suppliers. Flexible production systems capable of supporting multiple capsule sizes experienced demand growth of 29%. Emerging pharmaceutical manufacturing hubs in India, Southeast Asia, and the Middle East continue investing in modern production infrastructure, creating favorable conditions for equipment suppliers and technology developers.

New Product Development

Product innovation within the Softgel Machine Market is centered on automation, digitalization, and production efficiency. More than 68% of newly introduced systems incorporate touchscreen interfaces, programmable logic controllers, and remote monitoring capabilities. Manufacturers increasingly focus on reducing material waste, with next-generation machines improving gelatin utilization efficiency by 14%. Automated fill-weight monitoring systems enhance dosing accuracy above 98%, supporting pharmaceutical compliance requirements.

Vegetarian softgel compatibility remains a major innovation area. Approximately 22% of recently launched equipment models support plant-based capsule materials, addressing growing consumer demand for non-animal products. Integrated drying technologies reduce processing times by 17%, while automated sorting systems improve throughput by 20%. Manufacturers also introduced modular machine designs allowing faster product changeovers and simplified maintenance procedures. Smart manufacturing capabilities, including predictive maintenance and cloud-based performance monitoring, are now integrated into 43% of new equipment launches. These developments continue improving production consistency, operational efficiency, and manufacturing flexibility across pharmaceutical and nutraceutical industries.

Five Recent Developments (2023-2025)

• In 2025, multiple manufacturers introduced automated encapsulation systems capable of producing 120,000 capsules per hour, improving output efficiency by 18% compared with previous-generation equipment.
• In 2025, advanced vision inspection technologies achieved defect detection accuracy exceeding 97%, reducing rejection rates by approximately 14% across pharmaceutical production lines.
• In 2024, plant-based softgel compatible machinery installations increased by 26%, supporting expanding demand for vegetarian and non-gelatin capsule formulations.
• In 2024, digital monitoring integration reached 52% of newly commissioned softgel production lines, enabling real-time process validation and automated quality tracking.
• In 2023, energy-efficient drying systems reduced electricity consumption by 16% while improving drying performance and throughput across large-scale manufacturing facilities.

Report Coverage of Softgel Machine Market

The Softgel Machine Market report provides detailed analysis of equipment categories, applications, production technologies, regional performance, and competitive developments. The study evaluates soft capsule encapsulation machines, drying systems, and auxiliary equipment that collectively support pharmaceutical and nutraceutical manufacturing operations. Equipment segmentation includes automated and semi-automated production technologies, while application analysis covers pharmaceutical manufacturing, health supplements, cosmetics, veterinary products, and specialty nutrition sectors.

The report assesses market distribution across North America, Europe, Asia-Pacific, and Middle East & Africa, identifying regional market shares of 35%, 29%, 28%, and 8%, respectively. Analysis includes automation trends, production capacity developments, and technology adoption patterns influencing equipment procurement decisions. More than 58% of demand originates from pharmaceutical applications, while health supplements contribute 31%. The report further examines competitive positioning, product innovation strategies, investment activities, and manufacturing expansion projects. Coverage also includes developments in vegetarian softgel production, digital process monitoring, automated inspection technologies, and integrated production systems that continue shaping industry performance across global markets.

```